Filipa S. Carvalho

发表

Doxorubicin‐Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy

P. Oliveira, A. Moreno, R. A. Carvalho, 2014, Medicinal research reviews.

New derivatives of lupane triterpenoids disturb breast cancer mitochondria and induce cell death.

P. Oliveira, J. Holy, E. Perkins, 2014, Bioorganic & Medicinal Chemistry.

Dioxin-induced acute cardiac mitochondrial oxidative damage and increased activity of ATP-sensitive potassium channels in Wistar rats.

P. Oliveira, A. Moreno, M. Cordeiro, 2013, Environmental pollution.

Toxicity of lupane derivatives on anionic membrane models, isolated rat mitochondria and selected human cell lines: Role of terminal alkyl chains.

P. Oliveira, J. Holy, C. Morais, 2018, Chemico-biological interactions.

Cardiac cytochrome c and cardiolipin depletion during anthracycline-induced chronic depression of mitochondrial function.

P. Oliveira, M. S. Santos, A. Moreno, 2016, Mitochondrion.

Investigating drug-induced mitochondrial toxicity: a biosensor to increase drug safety?

P. Oliveira, S. Pereira, V. Sardão, 2009, Current drug safety.

Lipophilic caffeic and ferulic acid derivatives presenting cytotoxicity against human breast cancer cells.

Fernanda Borges, Jorge Garrido, P. Oliveira, 2011, Chemical research in toxicology.

Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol.

P. Oliveira, P. Monteiro, C. Diogo, 2011, Current pharmaceutical design.

Edelfosine and perifosine disrupt hepatic mitochondrial oxidative phosphorylation and induce the permeability transition.

P. Oliveira, F. Mollinedo, A. Burgeiro, 2013, Mitochondrion.

Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity.

P. Oliveira, K. Wallace, A. Burgeiro, 2017, Toxicology.

Mitochondrial Metabolism Drives Low-density Lipoprotein-induced Breast Cancer Cell Migration

P. Domingues, Bruno Bernardes de Jesus, S. Dias, 2023, Cancer Research Communications.